Physician profile
Lawrence Thrush
NPI 1356333405
$1,765.59
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,141 · 2020: $194 · 2021: $143 · 2022: $206 · 2023: $81.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $81.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $81.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $343.28 | 2019-2023 | |
| Genentech USA, INC. | $342.38 | 2019-2020 | |
| Csl Behring | $222.29 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $208.32 | 2019-2022 | |
| Glaxosmithkline, LLC. | $139.60 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $139.60 | 2019 | |
| Shire North American Group INC | $82.10 | 2019 | |
| Optinose US, INC. | $61.20 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.98 | 2021-2023 | Cuvitru |
| Alk-Abello, INC | $38.21 | 2019 | |
| Phadia US INC. | $29.30 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.50 | 2019 | |
| Pharming Healthcare, INC. | $14.80 | 2021 | |
| Kaleo, INC. | $14.13 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.41 | 2019 | |
| Pfizer INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Thrush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.